Association of BDNF Serum Concentrations with Central Serotonergic Activity: Evidence from Auditory Signal Processing

Disturbances of serotonergic neurotransmission in the brain have been implicated in the pathogenesis and maintenance of several psychiatric disorders. According to recent preclinical and clinical studies, the loudness dependence of auditory evoked potentials (LD) is related to the central serotonergic neurotransmission in humans. As the serotonergic phenotype has been reported to be associated with brain-derived neurotrophic factor (BDNF), we studied whether BDNF serum concentrations are related to LD in 109 healthy human volunteers (62 male, 47 female, age: 42.5±13.1 years). Pearson correlation showed a significant negative correlation between the BDNF serum concentrations and the LD measured at Fz (r=−0.259, p=0.007) and a trend for the Cz electrode (r=−0.185, p=0.055). Although this association needs to be replicated, the results are in line with the assumption that low serum BDNF levels reflect low central serotonergic neurotransmission as indicated by a strong LD.

[1]  S. Cheetham,et al.  POST-MORTEM STUDIES OF NEUROTRANSMITTER BIOCHEMISTRY IN DEPRESSION AND SUICIDE , 1991 .

[2]  André Beauducel,et al.  Sensation Seeking and Affective Disorders: Characteristics in the Intensity Dependence of Acoustic Evoked Potentials , 2000, Neuropsychobiology.

[3]  D. Laude,et al.  Motor Activity Increases Tryptophan, 5‐Hydroxyindoleacetic Acid, and Homovanillic Acid in Ventricular Cerebrospinal Fluid of the Conscious Rat , 1986, Journal of neurochemistry.

[4]  W. Pardridge Neurotrophins, neuroprotection and the blood-brain barrier. , 2002, Current opinion in investigational drugs.

[5]  A. Russo-Neustadt Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders. , 2003, Seminars in clinical neuropsychiatry.

[6]  C. Nemeroff,et al.  Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. , 1994, Clinical chemistry.

[7]  S. Whittemore,et al.  BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain , 1998, Journal of neuroscience research.

[8]  Andreas J Fallgatter,et al.  Electrophysiological indication for a link between serotonergic neurotransmission and personality in alcoholism , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  F. Chaouloff Influence of physical exercise on 5-HT1A receptor- and anxiety-related behaviours , 1994, Neuroscience Letters.

[10]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[11]  A. Russo-Neustadt,et al.  Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain , 2004, Pharmacology Biochemistry and Behavior.

[12]  R. Duman,et al.  Antidepressants and neuroplasticity. , 2002, Bipolar disorders.

[13]  Linda Carpenter,et al.  Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography , 1998, Biological Psychiatry.

[14]  L. Knorring,et al.  Biochemistry of the augmenting-reducing response in visual evoked potentials. , 1981, Neuropsychobiology.

[15]  J. Gallinat,et al.  BDNF Serum Concentrations in Healthy Volunteers are Associated with Depression-Related Personality Traits , 2004, Neuropsychopharmacology.

[16]  K. Lesch,et al.  Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF) , 2000, Neurochemistry International.

[17]  Jürgen Gallinat,et al.  The serotonin syndrome scale: first results on validity , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[18]  Pedro Rosa-Neto,et al.  Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. , 2004, Archives of general psychiatry.

[19]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[20]  J. Siuciak,et al.  Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF) , 1997, Pharmacology Biochemistry and Behavior.

[21]  M. Hamon,et al.  Up‐regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B‐dependent mechanisms , 2002, Journal of neurochemistry.

[22]  A. Gjerris Baseline studies on transmitter substances in cerebrospinal fluid in depression , 1988, Acta psychiatrica Scandinavica. Supplementum.

[23]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.

[24]  William A Banks,et al.  Transport of brain-derived neurotrophic factor across the blood–brain barrier , 1998, Neuropharmacology.

[25]  G. Karmos,et al.  Auditory-evoked potentials as indicator of brain serotonergic activity first evidence in behaving cats , 1997, Biological Psychiatry.

[26]  Valéria Csépe,et al.  Auditory Evoked Potentials Reflect Serotonergic Neuronal Activity—A Study in Behaving Cats Administered Drugs Acting on 5-HT1A Autoreceptors in the Dorsal Raphe Nucleus , 1999, Neuropsychopharmacology.

[27]  R. Lindsay,et al.  The Neurotrophins NT-4/5 and BDNF Augment Serotonin, Dopamine, and GABAergic Systems during Behaviorally Effective Infusions to the Substantia Nigra , 1994, Experimental Neurology.

[28]  C. Altar,et al.  Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  C. Katona,et al.  Biological aspects of affective disorders , 1991 .

[30]  J. Tiihonen,et al.  Reduced brain serotonin transporter binding in patients with panic disorder , 2004, Psychiatry Research: Neuroimaging.

[31]  C. Altar Neurotrophins and depression. , 1999, Trends in pharmacological sciences.

[32]  David R. Kaplan,et al.  BDNF Promotes the Regenerative Sprouting, But Not Survival, of Injured Serotonergic Axons in the Adult Rat Brain , 2000, The Journal of Neuroscience.

[33]  Margit Burmeister,et al.  A BDNF Coding Variant is Associated with the NEO Personality Inventory Domain Neuroticism, a Risk Factor for Depression , 2003, Neuropsychopharmacology.

[34]  B. Lerer,et al.  Functional effects of chronic electroconvulsive shock on serotonergic 5-HT1A and 5-HT1B receptor activity in rat hippocampus and hypothalamus , 2002, Brain Research.

[35]  Ruoyan Chen,et al.  Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation , 2002, Thrombosis and Haemostasis.

[36]  R. Meares,et al.  The effect of placebo and tricyclic antidepressants on cortical evoked potentials in depressed patients , 1979, Biological Psychology.

[37]  R. Nesse,et al.  Serotonin transporter and GABA(A) alpha 6 receptor variants are associated with neuroticism , 2003, Biological Psychiatry.

[38]  D. Senkowski,et al.  Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder , 2003, Biological Psychiatry.

[39]  Jörg Daumann,et al.  High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users , 2000, Neuropsychopharmacology.

[40]  G. Stotz,et al.  The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression , 2000, Psychopharmacology.

[41]  M. Gurney,et al.  Human platelets contain brain-derived neurotrophic factor , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  J. Mann,et al.  INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS , 1983, The Lancet.

[43]  P. K. Dey,et al.  Exercise training: Significance of regional alterations in serotonin metabolism of rat brain in relation to antidepressant effect of exercise , 1992, Physiology & Behavior.

[44]  Daniel Senkowski,et al.  Frontal and Temporal Dysfunction of Auditory Stimulus Processing in Schizophrenia , 2002, NeuroImage.

[45]  S. Awata,et al.  Electroconvulsive shock regulates serotonin transporter mRNA expression in rat raphe nucleus , 2001, Psychiatry and clinical neurosciences.

[46]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.

[47]  Y. Michotte,et al.  Effects of tryptophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food-deprived rats , 1996, Brain Research.

[48]  D. Weinberger,et al.  Serotonergic dysfunction, negative mood states, and response to alcohol. , 2001, Alcoholism, clinical and experimental research.

[49]  J. Gallinat,et al.  BDNF serum concentrations in healthy humans are associated with depression-related personality traits , 2005 .

[50]  L. Davis,et al.  Serotonin dysfunction disorders : A behavioral neurochemistry perspective. Discussion , 1996 .

[51]  L. Davis,et al.  Serotonin dysfunction disorders: a behavioral neurochemistry perspective. , 1996, The Journal of clinical psychiatry.

[52]  Daniel Senkowski,et al.  Allelic Variants of the Functional Promoter Polymorphism of the Human Serotonin Transporter Gene is Associated with Auditory Cortical Stimulus Processing , 2003, Neuropsychopharmacology.

[53]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  M. Schwald,et al.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets , 2002, Neuroscience Letters.

[55]  Pearse Ag The common peptides and the cytochemistry of their cells of origin. , 1980 .

[56]  R. Hellweg,et al.  Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation , 2003, Experimental Neurology.

[57]  Georg Juckel,et al.  Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: A new hypothesis , 1993, Biological Psychiatry.

[58]  J. Siuciak,et al.  BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration , 1996, Brain Research.

[59]  H. Manji,et al.  Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression , 2003, Biological Psychiatry.

[60]  D. Murphy,et al.  Primary Structure of the Human Platelet Serotonin Uptake Site: Identity with the Brain Serotonin Transporter , 1993, Journal of neurochemistry.

[61]  J. Staley,et al.  Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization. , 1995, Developmental biology.

[62]  Pt Jr Costa Revised NEO Personality Inventory and NEO Five-Factor Inventory , 1992 .

[63]  J. Mendlewicz,et al.  Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex , 1997, British Journal of Psychiatry.

[64]  R. Duman,et al.  Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.

[65]  I. Ferrier,et al.  5HT2 receptor changes in major depression , 1990, Biological Psychiatry.

[66]  R. M. González,et al.  Developmental impairment of auditory evoked N1/P2 component in rats undernourished in utero: its relation to brain serotonin activity. , 2001, Brain research. Developmental brain research.

[67]  C. Cotman,et al.  Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus , 2000, Neuroscience.